Status
Conditions
Treatments
About
Surgery is still the main treatment for esophageal cancer, however, the complication and mortality rate of open esophagectomy is high. As a result, the thoracoscopic- laparoscopic minimally invasive esophagectomy (MIE) was developed. The MIE mainly comprised two surgical approaches:
MIE McKeown approach (cervical anastomosis) and MIE Ivor-Lewis approach (intrathoracicanastomosis). The MIE with intrathoracic anastomosis (Ivor-Lewis) is increasingly used for the treatment of mid and lower esophageal cancers. Our study is trying to compare the safety, feasibility, and short-term and long- term outcomes between MIE Ivor-Lewis approach and MIE McKeown approach for the treatment of lower thoracic esophageal cancer and esophageal- gastric junction.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
(I) Patients with clinically staged T1-3N0-2M0 tumors; good cardiopulmonary function;
(II) Patients with lower thoracic esophageal tumors and esophageal- gastric junction tumor;
(III) Patients without a previous history of cancer;
(IV) Patients without a previous history of neck or chest surgery;
Exclusion criteria
(I) cardiopulmonary function not good enough for surgery;
(II) Patients with hybrid MIE
Primary purpose
Allocation
Interventional model
Masking
200 participants in 2 patient groups
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal